ES2187796T3 - Reactivo de peptidos que permiten la deteccion de citomegalovirus (cmv) humano. - Google Patents

Reactivo de peptidos que permiten la deteccion de citomegalovirus (cmv) humano.

Info

Publication number
ES2187796T3
ES2187796T3 ES97932819T ES97932819T ES2187796T3 ES 2187796 T3 ES2187796 T3 ES 2187796T3 ES 97932819 T ES97932819 T ES 97932819T ES 97932819 T ES97932819 T ES 97932819T ES 2187796 T3 ES2187796 T3 ES 2187796T3
Authority
ES
Spain
Prior art keywords
cmv
peptides
detection
antibodies
invention refers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97932819T
Other languages
English (en)
Inventor
De Crommert Johannes Marti Van
Jaap Michiel Middeldorp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux BV
Original Assignee
Organon Teknika BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Teknika BV filed Critical Organon Teknika BV
Application granted granted Critical
Publication of ES2187796T3 publication Critical patent/ES2187796T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN REACTIVO DE PEPTIDOS QUE COMPRENDE PEPTIDOS INMUNOQUIMICAMENTE REACTIVOS CON ANTICUERPOS DE CITOMEGALOVIRUS (CMV) HUMANO. ESTA INVENCION SE REFIERE TAMBIEN A NUEVOS ANTICUERPOS DIRIGIDOS CONTRA ESTOS PEPTIDOS O FRAGMENTOS DE ESTOS PEPTIDOS. SE REFIERE TAMBIEN A UNAS LINEAS CELULARES CAPACES DE PRODUCIR ANTICUERPOS MONOCLONALES. ESTA INVENCION SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA DETECCION DEL CMV O ANTICUERPOS DIRIGIDOS CONTRA EL CMV EN UN FLUIDO DE PRUEBA Y UN EQUIPO DE PRUEBA A UTILIZAR CUANDO SE APLICAN DICHOS PROCEDIMIENTOS DE DETECCION. ESTA INVENCION SE REFIERE TAMBIEN A LA DETECCION DEL CMV EN UN FLUIDO DE PRUEBA O UNA TOMA DE TEJIDO QUE UTILIZA ANTICUERPOS, MONOCLONALES Y POLICLONALES, DIRIGIDOS CONTRA ESTOS PEPTIDOS, QUE TIENEN LAS CARACTERISTICAS DE DETECCION DE PROTEINAS DEL CMV ENDOGENAS Y DE PROTEINAS DE CMV DESNATURALIZADAS.
ES97932819T 1996-07-12 1997-07-09 Reactivo de peptidos que permiten la deteccion de citomegalovirus (cmv) humano. Expired - Lifetime ES2187796T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201972 1996-07-12

Publications (1)

Publication Number Publication Date
ES2187796T3 true ES2187796T3 (es) 2003-06-16

Family

ID=8224180

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97932819T Expired - Lifetime ES2187796T3 (es) 1996-07-12 1997-07-09 Reactivo de peptidos que permiten la deteccion de citomegalovirus (cmv) humano.

Country Status (12)

Country Link
US (1) US6936251B2 (es)
EP (1) EP0960336B1 (es)
JP (1) JP4218985B2 (es)
KR (1) KR100624517B1 (es)
AT (1) ATE225942T1 (es)
AU (1) AU735981B2 (es)
DE (1) DE69716305T2 (es)
DK (1) DK0960336T3 (es)
ES (1) ES2187796T3 (es)
ID (1) ID19063A (es)
WO (1) WO1998002746A1 (es)
ZA (1) ZA976196B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919121B4 (de) * 1999-04-27 2012-08-02 F. Hoffmann-La Roche Ag Multimeres CMV-Antigen
EP1328540B1 (en) 2000-10-20 2005-03-23 City of Hope Immunoreactive peptidic ctl epitopes of human cytomegalovirus pp150
AUPR593101A0 (en) * 2001-06-26 2001-07-19 Council Of The Queensland Institute Of Medical Research, The Cytomegalovirus t cell epitopes
ITMI20012160A1 (it) * 2001-10-18 2003-04-18 Edoardo Marchisio Sistema immunoenzimatico per la caratterizzazione antigenica dell'infezione attiva da cytomegalovirus e cmv confirmation test
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
CA2677455A1 (en) * 2007-02-07 2008-08-14 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Recombinant antigens of human cytomegalovirus (hcmv)
DK2352759T3 (en) 2008-07-16 2017-12-18 Inst Res Biomedicine ANTIBODIES THAT NEUTRALIZE HUMAN CYTOMEGALOVIRUS AND USE THEREOF
WO2010148541A1 (zh) * 2009-06-26 2010-12-29 鑫品生医科技股份有限公司 含衍生自细胞巨大病毒的胜肽的免疫原组成物及使用方法
JP5712513B2 (ja) * 2010-07-07 2015-05-07 富士レビオ株式会社 ヒトサイトメガロウイルス感染の検出方法
NZ591514A (en) * 2011-03-03 2013-11-29 Kode Biotech Ltd Assay method
US10611800B2 (en) 2016-03-11 2020-04-07 Pfizer Inc. Human cytomegalovirus gB polypeptide
US11629172B2 (en) 2018-12-21 2023-04-18 Pfizer Inc. Human cytomegalovirus gB polypeptide
TWI810589B (zh) 2020-06-21 2023-08-01 美商輝瑞股份有限公司 人巨細胞病毒糖蛋白Ｂ（ｇＢ）多肽
CN116298269A (zh) * 2022-08-17 2023-06-23 浙江大学医学院附属第一医院 人类巨细胞病毒重组抗原特异性IgG抗体的酶联免疫检测试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU590656B2 (en) * 1985-12-06 1989-11-09 Teijin Limited Anti cytomegaloviral human monoclonal antibody and process for its preparation
CA1335429C (en) * 1986-03-07 1995-05-02 Geoffrey L. Smith Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor
DE3619902A1 (de) * 1986-06-13 1988-03-03 Biotechnolog Forschung Gmbh Cmv-dna-strukturen, expressionsvektor dafuer, cmv-proteinstrukturen und deren verwendung
EP0330051B1 (de) * 1988-02-24 1996-01-03 BEHRINGWERKE Aktiengesellschaft Strukturelles Phosphoprotein (pp28) des menschlichen Cytomegalovirus (HCMV), seine Herstellung und Verwendung
GB9014652D0 (en) * 1990-07-02 1990-08-22 Wellcome Found Antigen
DE4128684A1 (de) * 1991-08-29 1993-03-04 Behringwerke Ag Hcmv-spezifische peptide, mittel dazu und ihre verwendung
US5744298A (en) * 1991-08-29 1998-04-28 Behringwerke Aktiengesellschaft DNA sequences which encode immunoreactive HCMV-specific peptides
IT1266740B1 (it) * 1994-07-01 1997-01-14 Maria Paola Landini Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale
DE4426453C1 (de) * 1994-07-26 1995-11-02 Biotest Ag Rekombinant hergestellte Fusionsproteine des Cytomegalievirus und diese enthaltende diagnostische Testkits
EP0702083A3 (de) * 1994-07-26 1997-01-15 Biotest Ag Polypeptide und Fusionsproteine bestehend aus dem UL 57 Leserahmen bzw. dem C-terminalen Bereich des Tegumentproteins pp150 aus HCMV, entsprechende Oligonucleotide und Nachweis reagentien

Also Published As

Publication number Publication date
US20030119039A1 (en) 2003-06-26
US6936251B2 (en) 2005-08-30
AU735981B2 (en) 2001-07-19
EP0960336B1 (en) 2002-10-09
AU3623197A (en) 1998-02-09
JP2000514300A (ja) 2000-10-31
EP0960336A1 (en) 1999-12-01
DK0960336T3 (da) 2003-02-10
KR100624517B1 (ko) 2006-09-18
ID19063A (id) 1998-06-11
WO1998002746A1 (en) 1998-01-22
KR20000023701A (ko) 2000-04-25
JP4218985B2 (ja) 2009-02-04
DE69716305D1 (de) 2002-11-14
ZA976196B (en) 1998-09-01
ATE225942T1 (de) 2002-10-15
DE69716305T2 (de) 2003-06-26

Similar Documents

Publication Publication Date Title
ES2187796T3 (es) Reactivo de peptidos que permiten la deteccion de citomegalovirus (cmv) humano.
ECSP024409A (es) Anticuerpos de especificidad doble y metodos para la elaboracion y el uso de los mismos
CY1119291T1 (el) Πολυσθενη αντισωματα και χρησεις για αυτα
NO20012937D0 (no) Direkte spröytestöpt lukking og fremgangsmåte for denne
CY1107961T1 (el) Υλικα οφθαλμικων και ωτορινολαρυγγολογικων συσκευων
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
DK1259218T3 (da) Kosmetisk sammensætning til behandling af aldrende og/eller stresset hud
NO20054351L (no) Monoklonalt antistoff og hybridom som produserer dette
NI200800193A (es) Anticuerpos humanos anti-il-23, composiciones, métodos y usos.
DK1259547T3 (da) Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
NO20012911L (no) Fremvisningsanordning og fremgangsmåte for drift av samme
BR0215405A (pt) Composições e processos de uso de collajolie
ECSP10010653A (es) Anticuerpos anti-il-17a/il-17f de reactividad cruzada y métodos de uso de los mismos
PE20050712A1 (es) Anticuerpos rg1
BR0114978A (pt) Composições e métodos que são úteis no tratamento de condições ou doenças inflamatórias, metabólicas, e proliferativas celulares
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
NO20032542D0 (no) Dempede anti-CD28-antistoffer og anvendelse derav
NO20031860D0 (no) Kahalaolid F
CU23228A1 (es) Fragmentos de anticuerpos especificos para el antigeno carcinoembrionario humano (cea) secuencias de sus regiones variables y vectores para la expresion microbiana de los mismos
DE69504959D1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
ATE457318T1 (de) Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper
PT906268E (pt) Fluorenonas com substituicao alquiloxiamino e sua utilizacao como inibidores da proteina quinase c
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
ATE376184T1 (de) Epitop-untersuchung mit hla